Our analysts research early to late stage biotech stocks and pharma companies often. Receive these reports free of charge by joining our SMS/Text, mobile app or email alerts for free. You can join and see our recent coverage & track record here –http://tradersnewssource.com/traders-news-source-new-members/
Receive our biotech reports and more by email or mobile alerts text the keyword “Traders” to 25827
July 24th, 2019 – We are initiating long-term coverage on INmune Bio Inc. (NASDAQ: INMB) read our full report here Harnessing The Power of The Innate (Natural) Immune System
We are 100% Anti-Spam
FDA Approval Calendar and Finding Potential FDA Approval Catalyst Dates
BioPharmCatalyst provides a pharmaceutical data bank that keeps track of Biotech stocks, FDA approvals, Advisory Committee activity and Phase 2 & 3 Trial data. To access this calendar just click the link below.